Clinical trials involve the administration of an investigational new drug to human subjects under the supervision of qualified investigators in accordance with good clinical practice (GCP) requirements and after clearance by the Food and Drug Administration (FDA) of an investigational new drug (IND) application.
Further, an independent review board (IRB) for each institution participating in the clinical trial must review and approve the plan for any clinical trial, its informed consent form, and other communications to study subjects before the clinical trial commences at that site. The IRB must continue to oversee the clinical trial while it is being conducted, including any changes to the study plans.
Acrivon Therapeutics is currently recruiting patients in the United States for the following active clinical trials. Please follow the links below for more information for each study and site location.
